Osteoarthritis is the most common type of joint disease, affecting over 20 million individuals in the United States. Osteoarthritis of the hip commonly results in pain, restriction in range of motion and diminished participation in activities.
CH is an active 51y/o patient with a longstanding history of hip osteoarthritis who came to the Centeno-Schultz Clinic searching for an alternative to hip replacement. He underwent stem cell treatments and notes agreater thanb 75% improvement. He chose stem cell treatments as he wanted to avoid the complications associated with total hip replacement.
He underwent stem cell treatments in July 2010(Regenexx C) and Regenexx SD in August and November 2010.
Hip outcomes have been previsouly discussed in Dr. Centeno’s blog.
CH has returned to backpacking and recently sent this e-mail:
“I am happy to report on my progress following Regenexx C/SD on my hip. Prior to treatment, my last backpacking trip was January, 2009. Since then, I went through the stages of semi-immobility with osteoarthritis. Last weekend I went on my first Post-Regenexx backpacking trip of 32 miles in two days in Great Smoky Mountain National Park. This represents long daily mileage for advanced hikers in this terrain. Although I was apprehensive about trying such a long distance on my first trip out, I did fine. Just a few small blisters on my toes and sore muscles the day after I got back. I had a great time!
Stemcelldoc's Weblog 